共 50 条
- [32] Anatomy of an FDA Drug Recall: The 17α-Hydroxyprogesterone Accelerated Approval and Withdrawal Processes [J]. CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2024, 13 (03): : 171 - 179
- [34] Drugs with FDA accelerated approval often have weak evidence, study finds [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
- [35] Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 760 - 761
- [36] Animal models and their contribution to the FDA approval process for topical agents and devices [J]. WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2002, 14 (05): : 167 - 168
- [37] Impact of the US Accelerated Approval for New Anticancer Drugs on Time to Verification of Benefit and Regulatory Approval in the EU and Japan [J]. Therapeutic Innovation & Regulatory Science, 2024, 58 : 136 - 142
- [39] Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval [J]. Therapeutic Innovation & Regulatory Science, 2024, 58 : 387 - 394